News & Analysis on Clinical Trial Services & Contract Research And Development
The UK subsidiary of Nicholas Piramal (NPIL) is working on a new catalyst-based racemisation technology called SCRAM that delivers significantly improved process yields in the production of chiral amines and alcohols, cutting cost and environmental waste.
INC Research has expanded its late phase contract research capabilities with the purchase of a contract research organisation (CRO) in Philadelphia, US.
Ferro Pfanstiehl Laboratories has commissioned a new validated current good manufacturing practice (cGMP) supercritical fluid-based particle engineering pilot facility, offering sizing, purification and formulation services to its pharmaceutical...
Under pressure to respond to the spread of HIV in the developing world, Gilead has signed non-exclusive licence agreements with eight Indian generic companies for the manufacture of Viread (tenofovir disoproxil fumarate), its popular antiretroviral.
Chemir Analytical Services, the new owner of Gateway Chemical Technology, has renamed the custom chemical analysis business IQsynthesis in a revamp effort.
Automation equipment provider Contax has increased productivity and efficiency in one of AstraZeneca's packaging lines by installing a new specialist conveyor.
When it comes to managing an early phase research and clinical development programme, drug companies have three choices - each with their own pros and cons.